Mechanism of Hemolymph Coagulation System in Invertebrates
无脊椎动物血淋巴凝固系统的机制
基本信息
- 批准号:02454539
- 负责人:
- 金额:$ 4.48万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for General Scientific Research (B)
- 财政年份:1990
- 资助国家:日本
- 起止时间:1990 至 1991
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Limulus proclotting enzyme and factor b associated with endotoxin-sensitive coagulation cascade : novel serine protease zymogens with a new type of "disulfide-knotted domain"Horseshoe crab (Limulus) hemolymph responds to bacterial endotoxin and results in rapid coagulation. This reaction is composed of a cascade consisting of three serine protease zymogens (factor C, factor B, and proclotting enzyme) and a clottable protein (coagulogen), all of which are released by degranulation of the hemocytes on the stimutation of endotoxin. In the present paper, we describe the structures of proclotting enzyme and factor B. CDNA clonings of all the factors associated with this cascade were completed by this study. Proclotting enzyme is a single-chain glycoprotein with molecular mass of 54 kDa. Upon activation by factor B, it is converted to a two-chain active form clotting enzyme composed of an L (25 kDa) and a H (31 kDa) chains. A CDNA for proclotting enzyme encodes a sequence comprising 29 amino … More acid residues of prepro-sequence and 346 residues of the mature protein. Factor B (64 kDa) is also a glycoprotein that exists as a single-chain form and a two-chain zymogen form with an L (25 kDa) and a H (40 kDa) chains. Factor B zymogen is activated to B by active factor C, which is derived from the zymogen factor C that is sensitive to endotoxin. Factor B has 375 amino acid residues in the mature form, in addition to 25 residues of signal sequence. The entire amino acid sequences of the two proteins are similar, suggeting that these proteins were arisen from a gene duplication. Particularly, the sequence identity of serine protease domains at their C-terminus is calculated to be 43.9%. The N-terminal regions up to 60th residue of both proteins share a similar structure with six cysteines that has not been found in any other proteins. The disulfide locations determined on proclotting enzyme indicate that this region consists of a compact "disulfide-knotted domain". The sequence accompanied with the activation of proclotting enzyme was proven to be an Arg-Ile bond, whereas that of factor B, deduced from sequence alignments with other serine proteases, contained a unique-Arg-Gly-Ile-sequence. Less
与内毒素敏感的凝血级联反应的limulus propting酶和因子B:新型的丝氨酸蛋白Zymogens具有新型的“二硫化二硫键结域”类型的马蹄蟹(Limulus)血糖对细菌内毒素的反应,并导致快速凝结。该反应由级联反应组成,该级联反应由三种丝氨酸蛋白酶原(因子C,因子B和proclotting酶)和可蛋白质蛋白(凝结酶)组成,所有这些蛋白质(凝结剂)均通过对内毒素刺激的半细胞脱粒而释放。在本文中,我们描述了与该级联相关的所有因素的prot酶和因子B的结构。 proclotting酶是一种单链糖蛋白,分子质量为54 kDa。通过因子B激活后,将其转换为由L(25 kDa)和A H(31 kDa)链组成的两链活动形式凝结酶。用于protting酶的cDNA编码包含29个氨基的序列…更多的酸保留前序列和346个成熟蛋白的保留。因子B(64 kDa)也是一种糖蛋白,它作为单链形式和具有L(25 kDa)和A H(40 kDa)链的两链Zymogen形式存在。通过活性因子C激活B酶原因子C,该因子C源自对内毒素敏感的酶原因子C。因子B除了25个信号序列的残留物外,还具有375个氨基酸以成熟形式保留。两种蛋白质的整个氨基酸序列都是相似的,这表明这些蛋白质是由基因复制引起的。特别是,串行蛋白结构域在其C末端的序列身份计算为43.9%。两种蛋白质的N末端区域的N末端区域具有相似的结构,与六个半胱氨酸相似,在任何其他蛋白质中尚未发现。确定protting酶的二硫化物位置,表明该区域由紧凑的“二硫键打结结构域”组成。伴有proclotting酶激活的序列被证明是Arg-Eile键,而从与其他序列蛋白的序列对齐得出的因子B的序列含有一个独特的Arg-Gly-Gly-ei-Ele-sequencence。较少的
项目成果
期刊论文数量(86)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Takaenoki, Y., Muta, T., Miyata, T. and Iwanaga, S.: "cDNA and Amino Acid Sequence of Bovine Tissue Factor." Biochem. Biophys. Res. Communs.181. 1145-1150 (1991)
Takaenoki, Y.、Muta, T.、Miyata, T. 和 Iwanaga, S.:“牛组织因子的 cDNA 和氨基酸序列。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Yae,Y.,et al.: "Isolation and Characterization of “Thermolabile Substance"or“Hakata Antigen"Detercted by Precipitating(auto) Antibody in Sera of Patients with Systemic Lupua Erythematosus." Biochem.Biophys.Acta. 1078. 369-376 (1991)
Yae, Y., 等人:“系统性红斑狼疮患者血清中沉淀(自身)抗体检测到的“耐热物质”或“博多抗原”的分离和表征。Biochem.Biophys.Acta。 376 (1991)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Miyata, T. and Iwanaga, S.: "Molecular Aspects of Extrinsic Blood coagulation." Recent Advances in Thrombosis and Fibrinolysis (Ed. by K. Tanaka).Academic Press Inc.3-16 (1991)
Miyata, T. 和 Iwanaga, S.:“外源性血液凝固的分子方面”。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Tsuda, H., Miyata, T., Iwanaga, S. and Yamamoto, T.: "Analysis of Intrinsic Fibrinolysis in Human plasma Induced by Dextran Sulfate." Thrombosis and Haemostasis. (1991)
Tsuda, H.、Miyata, T.、Iwanaga, S. 和 Yamamoto, T.:“硫酸葡聚糖诱导的人血浆内源性纤维蛋白溶解分析”。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Morita, T., Fukudome, K., Miyata, T. and Iwanaga, S.: "gamma-Carboxyglutamic Acid (Gla) -Domainless Blood coagulation Factor IXa Species : Preparation and Properties." J. Biochem.110(6). 990-996 (1991)
Morita, T.、Fukudome, K.、Miyata, T. 和 Iwanaga, S.:“γ-羧基谷氨酸 (Gla) -无域凝血因子 IXa 种类:制备和特性。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
IWANAGA Sadaaki其他文献
IWANAGA Sadaaki的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('IWANAGA Sadaaki', 18)}}的其他基金
Role of Limulus Hemocytes in the Biological Defense System.
鲎血细胞在生物防御系统中的作用。
- 批准号:
04404090 - 财政年份:1992
- 资助金额:
$ 4.48万 - 项目类别:
Grant-in-Aid for General Scientific Research (A)
Basic studies on Development of Anti-thrombotic Agents
抗血栓药物开发的基础研究
- 批准号:
04557015 - 财政年份:1992
- 资助金额:
$ 4.48万 - 项目类别:
Grant-in-Aid for Developmental Scientific Research (B)
Molecular Mechanism of Extrinsic Blood Coagulation Pathway
外源性凝血途径的分子机制
- 批准号:
03044113 - 财政年份:1991
- 资助金额:
$ 4.48万 - 项目类别:
Grant-in-Aid for international Scientific Research
Studies on the Activity Measurement for Blood Proteases using their Monoclonal Antibodies
用单克隆抗体测定血液蛋白酶活性的研究
- 批准号:
02557016 - 财政年份:1990
- 资助金额:
$ 4.48万 - 项目类别:
Grant-in-Aid for Developmental Scientific Research (B)
Initiation Mechanism of Extrinsic Blood Coagulation System
外源性凝血系统的启动机制
- 批准号:
63044110 - 财政年份:1988
- 资助金额:
$ 4.48万 - 项目类别:
Grant-in-Aid for international Scientific Research
Development of Synthetic Fluorogenic Peptide Substrates for Blood Clotting Proteases
凝血蛋白酶合成荧光肽底物的开发
- 批准号:
63870017 - 财政年份:1988
- 资助金额:
$ 4.48万 - 项目类别:
Grant-in-Aid for Developmental Scientific Research
Hemolymph Coagulation and Defence Systems in Invertebrate Animals
无脊椎动物的血淋巴凝固和防御系统
- 批准号:
62480453 - 财政年份:1987
- 资助金额:
$ 4.48万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)
Development and Application of Fluorogenic Peptide Substrates for Determination fo Blood Clotting Proteases
凝血蛋白酶测定荧光肽底物的研制及应用
- 批准号:
61880016 - 财政年份:1986
- 资助金额:
$ 4.48万 - 项目类别:
Grant-in-Aid for Developmental Scientific Research
Studies on Molecular Abnormality of Blood Coagulation and Fibrinolytic Factors
凝血及纤溶因子分子异常研究
- 批准号:
60480497 - 财政年份:1985
- 资助金额:
$ 4.48万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)
相似国自然基金
基于炎症与血液高凝状态的关联研究促孕复方改善胚胎着床障碍及早期妊娠丢失的分子机制
- 批准号:81874388
- 批准年份:2018
- 资助金额:56.0 万元
- 项目类别:面上项目
阿加曲班改性滤器膜通过凝血酶介导的补体C5a/C5aR通路影响微炎症形成的机制研究
- 批准号:81800680
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
核壳模板-溶胀破壳法构筑类肝素结构凝胶微球
- 批准号:51773127
- 批准年份:2017
- 资助金额:55.0 万元
- 项目类别:面上项目
FⅡa-polyP-FⅫ级联反应在血液净化凝血中的作用及AG抗凝滤器对其影响
- 批准号:81670693
- 批准年份:2016
- 资助金额:58.0 万元
- 项目类别:面上项目
血小板FVIII基因治疗诱导血友病A小鼠FVIII免疫耐受研究
- 批准号:81500158
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
相似海外基金
A New Lipid Nanoparticle Technology Enabling Long-acting mRNA Therapy
新型脂质纳米颗粒技术实现长效 mRNA 治疗
- 批准号:
10669826 - 财政年份:2023
- 资助金额:
$ 4.48万 - 项目类别:
Novel approaches for the treatment of autoimmune disease
治疗自身免疫性疾病的新方法
- 批准号:
10601899 - 财政年份:2023
- 资助金额:
$ 4.48万 - 项目类别:
Development of a non-Factor small molecule, oral, prophylactic and hemostasis balanced therapy for treatment of clotting disorders including hemophilia A/B
开发非因子小分子、口服、预防性和止血平衡疗法,用于治疗包括血友病 A/B 在内的凝血障碍
- 批准号:
10384995 - 财政年份:2022
- 资助金额:
$ 4.48万 - 项目类别:
Overcoming FVIII protein misfolding and cell toxicity
克服 FVIII 蛋白错误折叠和细胞毒性
- 批准号:
10560541 - 财政年份:2022
- 资助金额:
$ 4.48万 - 项目类别:
B-cell response and thrombotic complications in COVID-19
COVID-19 中的 B 细胞反应和血栓并发症
- 批准号:
10552034 - 财政年份:2022
- 资助金额:
$ 4.48万 - 项目类别: